United States · FDA National Drug Code directory
Febuxostat
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-797_25711455-9482-c211-793c-6d09539f1c09
- Product NDC
- 55111-797
- Form
- TABLET
- Composition / generic term
- Febuxostat
- Labeler
- DR REDDY'S LABORATORIES LIMITED
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201125
- Source listing expiry
- 20261231
Source-listed ingredients
- FEBUXOSTAT — 80 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (55111-797-01) · 55111-797-01
- 500 TABLET in 1 BOTTLE (55111-797-05) · 55111-797-05
- 30 TABLET in 1 BOTTLE (55111-797-30) · 55111-797-30
- 90 TABLET in 1 BOTTLE (55111-797-90) · 55111-797-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →